Quick Takeaways
- Stonepine Capital Management, LLC filed SCHEDULE 13G/A for CNS Pharmaceuticals, Inc. Common Stock (CNSP).
- Disclosed ownership: 7.9%.
- Date of event: 31 Dec 2025.
Stonepine Capital Management, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for CNS Pharmaceuticals, Inc. Common Stock (CNSP)
- Filing Manager
- Stonepine Capital Management, LLC
- Reporting Manager
- Stonepine Capital Management, LLC
- Symbol
- CNSP
- Shares outstanding
- 618,063 shares
- Disclosed Ownership
- 48,827 shares
- Ownership
- 7.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 17:02:32 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 04 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Stonepine Capital Management, LLC disclosed 7.9% ownership in CNS Pharmaceuticals, Inc. Common Stock (CNSP) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 04 Nov 2025.
- Current filing was accepted on 13 Feb 2026, 17:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 7.9% | 48,827 | 0 | 48,827 | /s/ Jon M. Plexico | Managing Member | |
| Stonepine Capital, L.P. | 7.9% | 48,827 | 0 | 48,827 | /s/ Jon M. Plexico | Managing Member of the General Partner, Stonepine GP, LLC | |
| Stonepine GP, LLC | 7.9% | 48,827 | 0 | 48,827 | /s/ Jon M. Plexico | Managing Member | |
| Jon M. Plexico | 7.9% | 48,827 | 0 | 48,827 | /s/ Jon M. Plexico | Reporting person |